Understanding Biological Indicator Grow-Out Times - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Understanding Biological Indicator Grow-Out Times
This study used biological indicators containing   Geobacillus stearothermophilus spores and a new technology to continuously monitor incubated BIs and record nonsterile results.


Pharmaceutical Technology
Volume 34, Issue 1

References

1. ISO 11135-1: 2007 (ISO, Geneva, 2006).

2. ISO 17665-1:2006 (ISO, Geneva, 2006).

3. ISO 14161:2000 (ISO, Geneva, 2000).

4. ANSI/AAMI ST79:2006 (AAMI, Arlington, VA, 2006).

5. USP 32–NF 27 General Chapter < 1211 >, "Sterilization and Sterility Assurance of Compendial Articles," 720–723.

6. FDA, 21 CFR Part 820: Quality System Regulation. Medical Devices: Current Good Manufacturing Practice (cGMP); Final Rule Oct. 7, 1996.

7. ISO 11138-1:2006 (ISO, Geneva, 2006).

8. CDRH, FDA Guide for Validation of Biological Indicator Incubation Time (Do. 98984, 2007).

9. The ISO/TC198/WG 04 Biological Indicator working group has been assigned a new work item proposal ISO/TS 16342 "Sterilization of healthcare products – Biological indicators – Method for validation of a reduced incubation time for a biological indicator."

10. H. Chick, J. Hygiene, 8, 92–158, (1908).

11. W. D. Bigelow, J. Inf. Dis., 29, 528–536 (1921).

12. O. Rahn, Biodynamica Monograph 3, Luyet, B. J., ed, (1945). Republished in Selected papers on the Microbiology and Engineering of Sterilization Processes, I. J. Pflug, ed. (Environmental Sterilization Laboratory, Minneapolis, 5th ed. 1988) pp. 1–16.

13. I.J. Pflug, Microbiology and Engineering of Sterilization Processes (Environmental Sterilization Services, Minneapolis, MN, 11th ed., 2003).

14. G.A. Mosley, BI & T, 36 (6), 451–454 (2003).

15. ISO TR11139:2006 (ISO, Geneva, 2006).

16. H.O. Halverson and N.R Ziegler, Journ. of Bacteriology 25, 101–121 (1933).

17. G. Mosley, Pharm Micro Forum Newsletter, 14 (5), (2008).

18. I.J. Pflug, R.G. Holcomb, and M.M. Gomez, "Thermal Destruction of Microorganisms," in Disinfection, Sterilization, and Preservation, ed. S. Block (Philadelphia: Lippincott, Williams & Wilkins, 2001) pp. 79-129.

19. L. I. Katzin,.A. Sanholzer, and M.E. Strong, J. Bacteriol., 45, 265–272 (1943).

20. C. R. Stumbo, J. R. Murphy, and J. Cochran, Food Technology, 4,321–326 (1950).

21. A. D. Russell, The Destruction of Bacterial Spores (Academic Press, London, 1982).

22. A. Hurst and G. W. Gould, The Bacterial Spore 2 (Academic Press, London, 1983).

23. ISO 18472:2006. (ISO, Geneva, 2006).

24. ISO 11138-3:2006. (ISO, Geneva, 2006).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here